Human IL-8 / CXCL8 Protein, premium grade
分子別名（Synonym）
CXCL8,GCP1,IL8,LECT,LUCT,LYNAP,MDNCF,MONAP,NAF,NAP-1
表達區(qū)間及表達系統(tǒng)（Source）
Human IL-8 Protein, premium grade (IL8-H5217) is expressed from human 293 cells (HEK293). It contains AA Ser 28 - Ser 99 (Accession # P10145-1).
Predicted N-terminus: Ser 28
它是在我們嚴格的質量控制體系下生產的，該體系包含一套全面的測試，包括無菌和內毒素測試。在早期臨床前階段，產品性能經過仔細驗證和測試，以確保其與細胞培養(yǎng)用途或任何其他應用的兼容性。當準備過渡到后期臨床階段時，我們還提供定制的GMP蛋白質服務，以滿足您的需求。我們將與您合作，根據(jù)您的要求定制和開發(fā)GMP級產品，該產品也符合細胞療法細胞制造中使用的原材料和輔助材料的要求。
蛋白結構（Molecular Characterization）
This protein carries no "tag".
The protein has a calculated MW of 8.4 kDa. The protein migrates as 9 kDa±3 kDa under reducing (R) condition, and 11 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under non-reducing (NR) condition (SDS-PAGE) due to glycosylation.
內毒素（Endotoxin）
Less than 0.01 EU per μg by the LAL method.
宿主蛋白殘留（Host Cell Protein）
<0.5 ng/μg of protein tested by ELISA.
宿主核酸殘留（Host Cell DNA）
<0.02 ng/μg of protein tested by qPCR.
無菌（Sterility）
Negative
支原體（Mycoplasma）
Negative.
純度（Purity）
>95% as determined by SDS-PAGE.
>90% as determined by SEC-HPLC.
制劑（Formulation）
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構方法（Reconstitution）
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲（Storage）
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 24 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景（Background）
Interleukin 8 (IL8 or chemokine (C-X-C motif) ligand 8, CXCL8) is a chemokine produced by macrophages and other cell types such as epithelial cells, airway smooth muscle cells and endothelial cells. There are many receptors on the surface membrane capable of binding IL-8, the most frequently studied types are the G protein-coupled serpentine receptors CXCR1 and CXCR2. Expression and affinity for IL-8 differs between the two receptors (CXCR1 > CXCR2). IL-8(6-77) has a 5-10-fold higher activity on neutrophil activation, IL-8(5-77) has increased activity on neutrophil activation and IL-8(7-77) has a higher affinity to receptors CXCR1 and CXCR2 as compared to IL-8(1-77), respectively.
關鍵字： IL-8;IL-8蛋白;CXCL8重組蛋白;ACRO;百普賽斯;
百普賽斯集團ACROBiosystems Group（股票代碼：301080）是成立于2010年的跨國生物科技公司，是為全球生物醫(yī)藥、健康產業(yè)領域提供關鍵生物試劑產品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務遍布全球，橫跨亞洲、北美洲、歐洲，在中國、美國、瑞士等12個城市設有辦公室、研發(fā)中心及生產基地。目前累計服務客戶超6000家，與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學等。